This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Wistar Institute, The Wistar Institute of Anatomy and Biology, University of Pennsylvania. Active years: 2009-2025.
Company Filing History:
5 out of 246 
1 out of 15 
1 out of 2,645 
Years Active: 2009-2025
Title: Michael Showe: Innovator in Lung Cancer Diagnostics
Introduction
Michael Showe is a distinguished inventor based in Media, PA (US), known for his significant contributions to the field of cancer diagnostics. With a total of 6 patents, he has focused on developing innovative methods for diagnosing lung cancer through gene expression profiles.
Latest Patents
Among his latest patents, Showe has developed compositions and methods for diagnosing lung cancers using gene expression profiles. One of his notable inventions involves the use of 7 or more selected genes from the blood of a mammalian subject, which are characteristic of lung cancer. This gene expression profile is crucial for early detection and diagnosis. Additionally, he has created methods that utilize 10 or more selected genes, further enhancing the accuracy of lung cancer diagnosis.
Career Highlights
Throughout his career, Michael Showe has worked with prestigious institutions such as The Wistar Institute of Anatomy & Biology and the University of Pennsylvania. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer diagnostics.
Collaborations
Some of his notable coworkers include Louise C Showe and Andrew V Kossenkov, who have played significant roles in his research endeavors.
Conclusion
Michael Showe's innovative work in lung cancer diagnostics exemplifies the impact of research and invention in the medical field. His contributions continue to pave the way for advancements in early detection and treatment of lung cancer.